AI assistant
Sending…
NeuroPace Inc — Director's Dealing 2021
Apr 26, 2021
33194_dirs_2021-04-26_7dd8334a-a828-484b-9b54-c0b1872878fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-26
Reporting Person: KCK LTD. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-26 | Common Stock | C | 5595493 | $0.00 | Acquired | 5621111 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-26 | Series A' Prime Preferred Stock | $0.00 | C | 323591 | Disposed | Common Stock (323591) | Direct | |
| 2021-04-26 | Series B' Prime Preferred Stock | $0.00 | C | 5271902 | Disposed | Common Stock (5271902) | Direct |
Footnotes
F1: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.
More from NeuroPace Inc
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 23